CRISPR Medicine News - 18 February 2021 | CRISPR Approaches to Duchenne Muscular Dystrophy - CRISPR Medicine

Call for Papers: CRISPR-powered Biosensing


CRISPR Approaches to Duchenne Muscular Dystrophy

CRISPR-Cas is often seen as as the holy grail in medicine, with hopes that it will offer cures for for rare genetic diseases with poor or no treatment options. In our latest piece, we take a look at the current status of CRISPR gene editing for the treatment of Duchenne muscular dystrophy (DMD). Read it right here.

Career CRISPR Medicine

Thank you for now - more great reads are on the way!

And if you have questions or suggestions, you can reach out to us directly at We love hearing from readers!

Happy Reading!


p.s. You can follow CRISPR Medicine News on Twitter and LinkedIn. If someone forwarded this email to you, you can sign up for our newsletter yourself here.